Hamish Baillie Acquires 3,000 Shares of The Biotech Growth Trust PLC (LON:BIOG) Stock

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie purchased 3,000 shares of The Biotech Growth Trust stock in a transaction dated Wednesday, November 27th. The shares were bought at an average price of GBX 931 ($11.86) per share, for a total transaction of £27,930 ($35,575.09).

The Biotech Growth Trust Stock Performance

LON BIOG opened at GBX 965 ($12.29) on Friday. The stock has a fifty day simple moving average of GBX 1,002.92 and a 200-day simple moving average of GBX 1,000.08. The Biotech Growth Trust PLC has a twelve month low of GBX 741 ($9.44) and a twelve month high of GBX 1,068.36 ($13.61). The stock has a market cap of £310.05 million, a PE ratio of 466.18 and a beta of 0.50. The company has a current ratio of 0.33, a quick ratio of 0.00 and a debt-to-equity ratio of 13.03.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.